BioSpace News Archive

Business

GC Pharma Reports Full Year 2020 Results

GC Pharma, a South Korean biopharmaceutical company, announced unaudited financial results for the year ended 31 December 2019.

February 9, 2021
·
2 min read
Business

Q4 Report 2020 - invitation to conference call and audiocast

On Tuesday February 16, at 16.00 CET, IRRAS will host a conference call and an online presentation of its Q4 2020 interim report.

February 9, 2021
·
1 min read
Business

Metrion Biosciences Appoints John Montana as Non-Executive Director

Expansion of the Board of Directors will support the company’s further growth as an ion channels focused drug discovery CRO

February 9, 2021
·
1 min read
Business

Gartner Reports Fourth Quarter 2020 Financial Results

Gartner, Inc., the world’s leading research and advisory company, reported results for the fourth quarter 2020 and provided its financial outlook for the full year 2021.

February 9, 2021
·
16 min read
BioMidwest

Biodesix Publishes Data on New COVID-19 Artificial Intelligence (AI)-Based Algorithm for Use in Clinical Decision Support Systems

New Data Show AI-Based Algorithm Rapidly Predicts Risk of Severe Outcomes for Patients Hospitalized for COVID-19 Infection

February 9, 2021
·
5 min read
Pharm Country

Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin

Lannett and HEC to Co-develop Insulin Aspart; Lannett Granted Exclusive US Commercialization Rights

February 9, 2021
·
3 min read
Innate Pharma Advances Lacutamab Clinical Development Program

TELLOMAK trial progresses as cohort 2 of KIR3DL2-expressing mycosis fungoides patients advances to Stage 2 earlier than anticipated

February 9, 2021
·
9 min read
Business

Relief Announces Resignation of Thomaz Burckhardt as Member of the Board of Directors

RELIEF THERAPEUTICS Holding AG announces the resignation, effective immediately, of Board of Directors member Thomaz Burckhardt.

February 9, 2021
·
2 min read
Business

Moberg Pharmas Year-end report 2020

Moberg Pharma announced its intention to submit a registration application for MOB-015 in Europe in 2021. With a normal processing time of about 1.5 years, approval is expected in early 2023 and launch in Europe by the end of 2023.

February 9, 2021
·
6 min read
Business

SyntheticMR AB partners with United Imaging

SyntheticMR AB and United Imaging announced that they have signed a global license agreement, through which United Imaging will market and sell SyntheticMR’s product to customers globally.

February 9, 2021
·
3 min read